Riluzole blocks perioperative ischemia-reperfusion injury and enhances postdecompression outcomes in cervical spondylotic myelopathy
Riluzole blocks perioperative ischemia-reperfusion injury and enhances postdecompression outcomes in cervical spondylotic myelopathy
复制标题
DOI:
10.1126/scitranslmed.aac6524
复制
发表时间:
2015-12-02
影响因子:
17.1
通讯作者:
Fehlings, Michael G.
中科院分区:
文献类型:
--
作者:
Karadimas, Spyridon K.;Laliberte, Alex M.;Fehlings, Michael G.
Although surgical decompression is considered the gold standard treatment for cervical spondylotic myelopathy (CSM), a proportion of cases show postoperative decline or continue to exhibit substantial neurological dysfunction. To investigate this further, we first examined data from the prospective multicenter AOSpine North America CSM study, finding that 9.3% of patients exhibited postoperative functional decline (Delta mJOA,